Mesoblast | MSB - Capital Ordinaire

Prix De L'Action
2.06
Variation Quotidienne
0.01 0.49%
Mensuellement
-12.34%
Annuel
-7.62%
Q1 Prévisions
2.02




Capital Ordinaire Changement Date
Clinuvel Pharmaceuticals AUD 50.2M 77.11K 2025-12
Cochlear AUD 65.4M 1.12B 2025-12
CSL USD 482.13M 93.87M 2025-12
Pacific Edge NZD 1.02B 210.22M 2025-12
Paradigm Biopharmaceuticals AUD 428.52M 39.09M 2025-12
PYC Therapeutics AUD 597.24M 366.66M 2025-12
Ramsay Health Care AUD 229.93M 29.81K 2025-12
Sonic Healthcare AUD 4.15B 467K 2024-12
Starpharma Holdings AUD 419.92M 179.17M 2025-12
Telix Pharmaceuticals AUD 338.78M 379K 2025-12